The Hartford Healthcare Fund Class Y (HGHYX)
Fund Assets | 796.39M |
Expense Ratio | 1.03% |
Min. Investment | $250,000 |
Turnover | 40.00% |
Dividend (ttm) | 2.05 |
Dividend Yield | 4.99% |
Dividend Growth | n/a |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 27, 2024 |
Previous Close | 41.05 |
YTD Return | -5.02% |
1-Year Return | -14.49% |
5-Year Return | 7.58% |
52-Week Low | 39.24 |
52-Week High | 52.56 |
Beta (5Y) | 0.64 |
Holdings | 91 |
Inception Date | Apr 28, 2000 |
About HGHYX
The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The fund takes a broad approach to investing in the health care sector. It may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors.
Performance
HGHYX had a total return of -14.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.11%.
Top 10 Holdings
46.52% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 12.89% |
UnitedHealth Group Incorporated | UNH | 6.80% |
Boston Scientific Corporation | BSX | 4.90% |
Intuitive Surgical, Inc. | ISRG | 4.17% |
Merck & Co., Inc. | MRK | 3.69% |
Vertex Pharmaceuticals Incorporated | VRTX | 3.34% |
Johnson & Johnson | JNJ | 2.91% |
Cencora, Inc. | COR | 2.89% |
Gilead Sciences, Inc. | GILD | 2.47% |
Thermo Fisher Scientific Inc. | TMO | 2.46% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 27, 2024 | $0.14994 | Dec 30, 2024 |
Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
Dec 10, 2020 | $5.16605 | Dec 11, 2020 |
Dec 10, 2019 | $2.36232 | Dec 11, 2019 |